Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee

This study has been completed.
Information provided by (Responsible Party):
Gebro Pharma GmbH Identifier:
First received: February 9, 2010
Last updated: July 9, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)